XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Oct. 01, 2022
Sep. 25, 2021
Oct. 01, 2022
Sep. 25, 2021
Product sales $ 6,748,117 $ 5,514,872 $ 20,471,574 $ 16,242,762
Total Revenues 6,748,117 5,514,872 20,471,574 16,242,762
Cost of product sales 4,864,876 4,375,676 14,796,206 12,807,844
Gross Margin 1,883,241 1,139,196 5,675,368 3,434,918
Selling, general and administrative expense 1,174,581 1,227,258 3,750,131 3,234,344
Operating income (loss) 708,660 (88,062) 1,925,237 200,574
Interest income (expense), net (1,892) (2,633) (6,245) (32,776)
Other income (expense), net 645,594 18,665 649,628 30,728
Net income (loss) before income tax expense 1,352,362 (72,030) 2,568,620 198,526
Income tax provision (benefit) 364,497 (2,799,997) 706,211 (2,799,541)
Net income $ 987,865 $ 2,727,967 $ 1,862,409 $ 2,998,067
Net income per basic common share (in dollars per share) $ 0.07 $ 0.19 $ 0.13 $ 0.21
Weighted average Common shares Outstanding (in shares) 14,434,468 14,324,136 14,417,995 13,963,563
Net income per diluted common share (in dollars per share) $ 0.07 $ 0.18 $ 0.13 $ 0.21
Weighted average number of diluted common shares outstanding (in shares) 14,686,476 14,811,259 14,683,632 14,542,356